{"id":"https://openalex.org/W1576532110","doi":null,"title":"Circulating endothelial cells in preclinical models of cancer","display_name":"Circulating endothelial cells in preclinical models of cancer","publication_year":2006,"publication_date":"2006-10-01","ids":{"openalex":"https://openalex.org/W1576532110","mag":"1576532110"},"language":"en","primary_location":{"id":"mag:1576532110","doi":null,"is_oa":false,"landing_page_url":"https://clincancerres.aacrjournals.org/content/12/19_Supplement/A49","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087951266","display_name":"Evelyn Mary McKeegan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evelyn McKeegan","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021063321","display_name":"Daniel H. Albert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel H. Albert","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038177916","display_name":"Paul Tapang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Tapang","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014399246","display_name":"Terry J. Magoc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terry Magoc","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001511809","display_name":"Cherrie K. Donawho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cherrie K. Donawho","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043511699","display_name":"Amanda L. Niquette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Niquette","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042093952","display_name":"Jason A. Stavropoulos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Stavropoulos","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028407662","display_name":"Laura M. McKay","orcid":"https://orcid.org/0009-0000-3215-634X","observed_orcids":["https://orcid.org/0009-0000-3215-634X"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura M. McKay","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016943284","display_name":"Abdullah Kherzai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abdullah Kherzai","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000025451","display_name":"Jack Henkin","orcid":"https://orcid.org/0000-0003-4226-3688","observed_orcids":["https://orcid.org/0000-0003-4226-3688"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack Henkin","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL"],"raw_orcid":"https://orcid.org/0000-0003-4226-3688","affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010161697","display_name":"Nancy Xie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Xie","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045161705","display_name":"Rick Lesniewski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rick Lesniewski","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210088555"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12278","display_name":"Vascular Tumors and Angiosarcomas","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/circulating-endothelial-cells","display_name":"circulating endothelial cells","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.9309999942779541},{"id":"https://openalex.org/keywords/tumor-markers","display_name":"tumor markers","score":0.593999981880188},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.7599999904632568},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7829999923706055},{"id":"https://openalex.org/keywords/b16-melanoma","display_name":"B16 melanoma","score":0.9589999914169312},{"id":"https://openalex.org/keywords/prostate-cancer-xenografts","display_name":"prostate cancer xenografts","score":0.8330000042915344},{"id":"https://openalex.org/keywords/endothelial-activation","display_name":"endothelial activation","score":0.8610000014305115},{"id":"https://openalex.org/keywords/endoglin","display_name":"CD105","score":0.8309999704360962},{"id":"https://openalex.org/keywords/endothelial-cell-apoptosis","display_name":"endothelial cell apoptosis","score":0.8209999799728394},{"id":"https://openalex.org/keywords/preclinical-cancer-models","display_name":"preclinical cancer models","score":0.6069999933242798},{"id":"https://openalex.org/keywords/tumor-volume","display_name":"tumor volume","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C2777751087","wikidata":"https://www.wikidata.org/wiki/Q5636047","display_name":"HT1080","level":3,"score":0.6256203651428223},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6227737069129944},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6147163510322571},{"id":"https://openalex.org/C2778939058","wikidata":"https://www.wikidata.org/wiki/Q4046167","display_name":"CD31","level":3,"score":0.5730286836624146},{"id":"https://openalex.org/C2776495794","wikidata":"https://www.wikidata.org/wiki/Q1362453","display_name":"Fibrosarcoma","level":2,"score":0.5431067943572998},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5192371010780334},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.46346819400787354},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.42413759231567383},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.381689190864563},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3680461049079895},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36025580763816833},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33956772089004517},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24843749403953552}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1576532110","doi":null,"is_oa":false,"landing_page_url":"https://clincancerres.aacrjournals.org/content/12/19_Supplement/A49","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W85078242","https://openalex.org/W2332168754","https://openalex.org/W1523263051","https://openalex.org/W4230761681","https://openalex.org/W2301220554","https://openalex.org/W2146700377","https://openalex.org/W2357046104","https://openalex.org/W2048829586","https://openalex.org/W2126313084","https://openalex.org/W2156517690"],"abstract_inverted_index":{"A49":[0],"Circulating":[3],"endothelial":[4],"cells":[5,16,270],"(CEC)":[6],"are":[7,126,136],"detected":[8,127,193],"at":[9,194],"elevated":[10,122,229],"concentrations":[11,93],"in":[12,97,128,141,149,152,188,198,209,215,230,236,261,303],"cancer":[13,85,145],"patients.":[14],"Endothelial":[15],"contribute":[17],"to":[18,28,133,146,154,245],"tumor":[19,30,70,99,116,155,157,170,231,237,294],"angiogenesis":[20,310],"by":[21,257,271],"incorporation":[22],"into":[23],"newly":[24],"forming":[25],"blood":[26],"vessels":[27],"support":[29],"growth":[31,171],"and":[32,61,69,86,101,112,118,163,181,220,234,264,290],"metastasis.":[33],"A":[34,63],"set":[35],"of":[36,83,124,144,165,191,206,249,259,268],"flow":[37],"cytometry":[38],"reagents":[39],"for":[40,74],"murine":[41,76],"models":[42,77,117,143,217],"has":[43,277,296],"been":[44,95,213,278,297],"established.":[45],"The":[46],"enumerated":[47],"mouse":[48],"CEC,":[49,251],"demonstrate":[50,185],"the":[51,79,87,189,195,247,250,253,262,265,269,273,281],"following":[52],"phenotype":[53],"CD31":[54],"+":[55,57],"/CD34":[56],"/CD45":[58],"-":[59],"nucleated.":[62],"positive":[64],"relationship":[65,153],"between":[66,285],"CEC":[67,92,125,139,192,210,226,263,286,299],"concentration":[68,211],"volume":[71,295],"was":[72],"determined":[73],"11/12":[75],"including":[78,177,218],"PC3":[80],"xenograft":[81,90],"model":[82],"prostate":[84],"HT1080":[88,106,282],"sarcoma":[89],"model.":[91],"have":[94,212],"characterized":[96],"normal,":[98],"bearing":[100,232,238],"tumor-bearing":[102,129],"compound-treated":[103],"mice":[104,130,233,239],"using":[105,174],"(human":[107],"fibrosarcoma),":[108],"B16":[109],"(murine":[110,114],"melanoma)":[111],"bEND.3":[113],"hemangioma)":[115],"indicate":[119],"that":[120,225],"an":[121],"number":[123,190,227],"when":[131],"compared":[132],"normal":[134],"mice.We":[135],"conducting":[137],"systematic":[138],"analysis":[140],"preclinical":[142],"study":[147],"changes":[148,208],"this":[150],"biomarker":[151],"type,":[156],"burden,":[158],"compound":[159],"dose,":[160],"dose":[161],"regimen,":[162],"class":[164],"compound.":[166],"Preliminary":[167],"data":[168],"from":[169],"inhibition":[172],"studies":[173],"angiogenisis":[175],"inhibitors,":[176,184],"TSP":[178],"mimetic":[179],"peptides":[180],"tyrosine":[182],"kinase":[183],"a":[186],"decrease":[187],"treatment":[196],"endpoints":[197],"drug-treated":[199],"animals":[200],"vs.":[201],"vehicle-treated":[202],"controls.":[203],"Time-course":[204],"analyses":[205],"these":[207],"performed":[214],"several":[216],"HT-1080":[219],"B16.":[221],"Further,":[222],"having":[223],"shown":[224],"is":[228],"reduced":[235],"treated":[240],"with":[241,293,308],"anti-angiogenic":[242],"agents,":[243],"experiments":[244],"explore":[246],"characteristics":[248],"specifically,":[252],"activation":[254,288],"status":[255,267,289],"demonstrated":[256],"co-expression":[258],"CD105":[260],"apoptotic":[266,291],"measuring":[272],"annexin":[274],"V":[275],"positivity":[276],"explored.":[279],"Using":[280],"model,":[283],"correlations":[284],"concentration,":[287],"state":[292],"observed.":[298],"will":[300],"be":[301],"monitored":[302],"patients":[304],"undergoing":[305],"clinical":[306],"trials":[307],"our":[309],"inhibitors.":[311]},"counts_by_year":[],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2016-06-24T00:00:00"}